Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT03467074 |
Date of registration:
|
06/03/2018 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Role of Interferon-? and Vaccine Response
|
Scientific title:
|
Association of Genetic Polymorphisms in the Interferon-? Signaling Cascade and Immune Response After Vaccination |
Date of first enrolment:
|
September 1, 2014 |
Target sample size:
|
200 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT03467074 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Switzerland
| | | | | | | |
Contacts
|
Name:
|
Adrian Egli, PD MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Department of Clinical Microbiology |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- held allogeneic stem cell transplantation over 1 year ago
Exclusion Criteria:
- Known vaccine intolerance (e.g. Protein allergy or severe vaccine-associated side
effects, e.g. Guillian Barré syndrome)
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Vaccine Response Impaired
|
Allogeneic Stem Cell Transplantation
|
Intervention(s)
|
Biological: influenza A/B vaccine
|
Primary Outcome(s)
|
Peripheral Blood Mononuclear Cells (PBMCs) in blood before vaccination
[Time Frame: Change from baseline PBMCs at day 60]
|
Peripheral Blood Mononuclear Cells (PBMCs) in blood after vaccination
[Time Frame: Change from baseline PBMCs at day 60]
|
Secondary ID(s)
|
2014-141; me15Egli
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|